Skip to main content
. 2019 Apr 16;8(6):3206–3215. doi: 10.1002/cam4.2142

Figure 1.

Figure 1

AORs associated with HCC by race/ethnicity (aOR associated with metformin use was adjusted for covariates, inverse propensity scores weighting of metformin use for each race/ethnic group, and inverse propensity scores weighting of race/ethnicity group membership). aORs, adjusted odds ratios; HCC, hepatocellular carcinoma